Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,876 shares at $103.03 ($704K) on 2020-02-05, disclosed to the SEC on 2020-02-07.
Seasonal sale ($704k) by Chief Regulatory Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.03 | 1,083 | $112K | 15.8% |
| 2 | $103.03 | 1,083 | $112K | 15.8% |
| 3 | $103.06 | 865 | $89K | 12.7% |
| 4 | $103.06 | 865 | $89K | 12.7% |
| 5 | $101.52 | 1,490 | $151K | 21.5% |
| 6 | $101.52 | 1,490 |
| $151K |
| 21.5% |
| Total | $102.38 avg | 6,876 | $704K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |